India Covid Vaccine Doses
- All
- News
- Videos
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Man Who Took 217 Covid Vaccines Has Fully Functional Immune System: Study
Researchers have examined a man in Germany who claims to have received 217 vaccinations against COVID-19 and found that his immune system was fully functional.
-
"No Rise In Hospitalisation, Deaths": Covid Panel Chief On Surge In Cases
Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.
-
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.
-
Odisha Requests Centre For 50,000 Vaccines Amid Covid Spike
With more than 100 cases of coronavirus being reported in Odisha for four days now, the state government Tuesday requested the Centre for at least an additional 50,000 doses of vaccine.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospital: Bharat Biotech
Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
No Need For 4th Dose Of Covid Vaccine Given Current Evidence: Expert
Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Government Health Facilities In Lucknow Run Out Of Covid Vaccine Doses: Report
The four government COVID-19 vaccination centres in the state capital have run out of vaccines, making it difficult for people to get a precautionary dose, an official said on Wednesday.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Man Who Took 217 Covid Vaccines Has Fully Functional Immune System: Study
Researchers have examined a man in Germany who claims to have received 217 vaccinations against COVID-19 and found that his immune system was fully functional.
-
"No Rise In Hospitalisation, Deaths": Covid Panel Chief On Surge In Cases
Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.
-
Current Covid Strain Mild, 5-6 Million Covovax Doses Made: Adar Poonawalla
The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company's chief executive officer Adar Poonawalla.
-
Odisha Requests Centre For 50,000 Vaccines Amid Covid Spike
With more than 100 cases of coronavirus being reported in Odisha for four days now, the state government Tuesday requested the Centre for at least an additional 50,000 doses of vaccine.
-
Covovax Booster Dose To Be Available On CoWIN, Cost Rs 225: Report
Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday.
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospital: Bharat Biotech
Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
No Need For 4th Dose Of Covid Vaccine Given Current Evidence: Expert
Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Government Health Facilities In Lucknow Run Out Of Covid Vaccine Doses: Report
The four government COVID-19 vaccination centres in the state capital have run out of vaccines, making it difficult for people to get a precautionary dose, an official said on Wednesday.
